Zomedica (NYSEAMERICAN:ZOM) is not having a good time. Retail investors have by and large thrown in the towel for the pet health care company. ZOM stock was recently changing hands for 58 cents, a far cry from the 52-week high of $2.91 per share. Source: didesign021 / Shutterstock.com Now, does that mean it is time to…

Zomedica (NYSEAMERICAN:ZOM) stock was said to be going “to the moon” on Reddit early this year. ZOM did zoom, to as high as $2.50 per share, twice. Source: didesign021 / Shutterstock.com Since mid-March the air has gone out of the balloon. ZOM stock is trading at about 58 cents. That gives it a market cap…

Zomedica (NYSEAMERICAN:ZOM) is the “meme stock” that just can’t take off. Despite constant prodding from Reddit and even some positive opinions from InvestorPlace, this pet health company remains in the penny stock dungeon. In fact, ZOM stock shares haven’t traded above $1 since April. Source: didesign021 / Shutterstock.com Fortunately, though, help is on the way…

Retail investors have by-and-large thrown in the towel on Zomedica (NYSEAMERICAN:ZOM) stock. Starting late last year, shares in the pet health care company took off, thanks to the buzz surrounding its Truforma testing product. Then, with the first wave of “meme stock madness,” prices went parabolic yet again, briefly hitting prices nearing $3 per share.…